Premeeting Workshop:
PW07. Hepatitis C Workshop
Wednesday, October 3, 2018: 8:00 AM-12:00 PM
Room: S 156

Handouts
  • W76-Wyles-Staging of HCV Patient-NEW.pdf (1.1 MB)
  • W77-Marks-Optimizing Initial Therapy-UPDATED.pdf (2.2 MB)
  • W78-Wyles-Resistance Testing-UPDATED.pdf (1.1 MB)
  • W79-Tien-Fatty Liver Disease-UPDATED.pdf (1.1 MB)
  • W80-Godofsky-Hepatology 101 for ID Clinicians-NEW.pdf (917.0 kB)
  • W81-Frenette-Hepatitis B Update-NEW.pdf (1.7 MB)
  • Learning Objectives:

    At the conclusion of this session, participants will
    be able to:

    • discuss how to design the treatment options for HCV patients according to their RAVS, treatment experience, HCV genotype, and disease stage
    • compare methods for staging liver disease
    • distinguish steatosis from steatohepatitis
    • explain how to diagnose common liver diseases

    Target Audience: Clinicians, HIV clinicians, HIV specialists, Infectious diseases pediatricians, Infectious diseases physicians, Pharmacists

    Tracks: Pediatric ID, HIV-STD-TB, Adult ID


    Pre-Meeting Workshop Moderator:  Eliot Godofsky, MD, FIDSA, Bach and Godofsky

    Presentations:
    8:00 AM
    Introduction
    8:35 AM
    W77
    Optimizing Initial Therapy
    Kristen M. Marks, MD

    9:45 AM
    Break
    10:35 AM
    W80
    Hepatology 101 for ID Clinicians
    Eliot Godofsky, MD, FIDSA

    11:10 AM
    W81
    Hepatitis B Update
    Catherine Frenette, MD, FAST, AGAF

    11:45 AM
    Final Q&A and Wrap Up

    CME Credits: Maximum of 4.00 hours of AMA PRA Category 1 Credit™

    ACPE Credits: ACPE 4 knowledge-based contact hours of pharmacy CE

    ACPE Number: 0221-9999-18-302-L01-P

    Disclosures:

    E. Godofsky, Practice Point Communications CME lecture series: Speaker's Bureau , Speaker honorarium .

    See more of: Premeeting Workshop

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.